Supplementary Material – ECZTRA 5 Manuscript
Published: 12 March 2021| Version 1 | DOI: 10.17632/85kp39n3nr.1
Contributors:
, , , , , , Description
Supplementary Information to accompany and support the manuscript: Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults With Moderate-to-severe Atopic Dermatitis.
Files
Institutions
LEO Pharma A/S, University of Alberta, Harvard Medical School
Categories
Dermatology, Vaccine, Immune Response, Atopic Dermatitis